Product information and disease descriptionPlace of product in therapyApproaches to treatment
Heterogeneity of treatment effect
9 evidence topics · 9 sources
MuSK antibody-positive disease: response to conventional therapies
“Many patients with MuSK-MG respond poorly to ChEIs, and conventional pyridostigmine doses frequently induce side effects.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Patients with MuSK-MG appear to respond well to corticosteroids and to many steroid-sparing IS agents. They tend to remain dependent on prednisone despite concomitant treatment with steroid-sparing agents.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“MuSK-MG responds well to PLEX, while IVIg seems to be less effective.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
MuSK antibody-positive disease: complement independence and thymectomy
“The observation of predominant IgG4 antibodies in patients with MuSK MG is indicative of immune response that corresponds with the IgG4 autoimmune diseases ( 9 ) and the antiinflammatory properties of the IgG4 that include the inability to activate complement.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The thymus is normal ( 116 ), and thymectomy does not benefit patients with MuSK with MG” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Rituximab response by antibody status
“A retrospective combined analysis of previously published case reports of 169 patients between January 2000 and August 2015 reported that 72% of MuSK-Ab + MG and 30% of AChR-Ab+ MG patients treated with RTX achieved MM status or better.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Seronegative disease: efgartigimod in anti-AChR antibody-negative adults
Antibody subgroups enrolled in FcRn blocker trials
Ocular versus generalized disease
“In 20% of MG patients, the muscle weakness remains confined to the extraocular muscles” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote